Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs Gala Health

HealthRX
Graded #9

Level

vs
Gala Health
Graded #8

Level

The verdict

Too close to call — both grade 86/100 (B).

HealthRX and Gala Health land on the same WeighScore, so neither clears the other on our six graded dimensions. Gala Health sits one line higher on the board (#8 vs #9) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGala Health +5
85
90
Dose & formulationHealthRX +7
90
83
Clinical oversightHealthRX +2
87
85
Labs & monitoringGala Health +1
82
83
FulfillmentGala Health +2
86
88
Contract termsGala Health +1
85
86
HealthRX · left barGala Health · right bar

The numbers

MetricHealthRXGala Health
WeighScore86/10086/100
GradeBB
Scorecard rank#9#8
Semaglutide$189/moNot disclosed
Tirzepatide$349/mo$179/mo
CoverageNot publicly listedAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
HealthRX

Graded #9 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
Gala Health

Graded #8 · B

Strengths

  • Low compounded entry — tirzepatide $179/mo, microdose from $149, 3-month plans from $199
  • Available in all 50 states
  • Keeps a brand-name path open (Ozempic listed at $1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with a shorter public record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 31 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard